Why Alzheimer's Speech Screening Fails to Generalize: Bridging the Deployment Gap via Cross-Corpus Evidence Anchoring

Speech-based Alzheimer's disease (AD) detection increasingly relies on speech-enhanced and curated versions of the Pitt Corpus, where speech enhancement, sample selection, and demographic balancing are often treated as beneficial preprocessing steps. However, whether these transformations improve real-world AD detection or instead affect model generalization and prediction behavior remains unclear. In this work, we revisit the role of speech preprocessing and dataset curation across widely used benchmarks for speech-based AD detection. We evaluate the speech quality of different datasets, the cross-dataset generalization of multiple deep learning models under matched and mismatched enhancement settings, and the behavior of several recent large audio-language models (LALMs). Experimental results show that across multiple supervised speech models, speech-enhanced datasets often improve in-domain performance while reducing robustness in cross-domain evaluation. Matched enhancement between training and test data alleviates, but does not eliminate, this degradation. LALMs show a similar sensitivity: enhanced datasets induce stronger class imbalance and prediction shifts than unprocessed data. These results suggest that speech preprocessing and dataset curation can substantially influence downstream AD detection behavior, indicating that ``cleaner'' speech datasets are not necessarily more reliable for real-world AD detection.

As Alzheimer's disease (AD) has increasingly become a major global public health issue, speech-based AD detection has attracted widespread attention. However, most existing methods are trained and evaluated on a single dataset, often leading to severe cross-domain performance degradation due to reliance on dataset-specific artifacts rather than disease-related speech cues. In real-world applications, reliable Alzheimer's disease detection requires models that are robust to variations in recording environments, speakers and data collection conditions. To address this challenge, this paper adopts unsupervised domain adaptation to learn robust, domain-invariant feature representations in the absence of target-domain diagnosis labels. On this basis, a novel unsupervised domain adaptation method, Iterative Adversarial Self-Training (IAST), is proposed. Results demonstrate that IAST significantly improves the generalization ability and robustness under various cross-domain settings.

Alzheimer's disease (AD) and mild cognitive impairment (MCI), which may precede AD, manifest early through subtle linguistic and acoustic alterations. Traditional diagnostics, however, are often resource-intensive and lack scalability for mass screening. To address these challenges, we introduce a novel bilingual speech large language model framework for automated, explainable cognitive screening. Unlike conventional pipelines that rely on error-prone automatic speech recognition, our system directly processes raw speech to learn joint acoustic-semantic representations, preserving critical prosodic cues often lost in transcription. Utilising our newly collected PUTH-AD dataset alongside multiple open-source corpora, we implemented a multi-task learning objective that simultaneously performs cognitive status classification and generates clinician-understandable natural language explanations. Our system achieved the highest average accuracy and AUROC across six dataset/task conditions, comparing three representative baselines. The system demonstrated cross-task transfer to held-out PUTH-AD task subsets, maintaining classification accuracy on an entirely unseen cognitive task without task-specific fine-tuning. Furthermore, clinician evaluation confirms that the generated explanations are both clinically relevant and largely consistent with the underlying speech evidence, supporting their potential utility in clinical interpretation. This study provides a scalable, objective, and explainable framework for speech-based cognitive screening, combining cognitive status classification with natural language explanations that clinicians can assess and verify, bridging the gap between advanced AI and clinical utility.